Long-term follow-up to week 104 in the S-LiTE trial demonstrated differing legacy effects
Book a Consultation Catherine Leonard Leonard ARNP, FNP-BC Accepting New Patients Frequently Asked Questions How do I know if GLP-1 therapy is right for me? The best way to know is through a consultation
The combination of reduced carbohydrate intake and slowing of glucose absorption also reduces postprandial glycemia and insulinemia and may be the dominant weight-loss-independent effect on type 2 diabetes and cardiovascular disease
At 2.5mg/mL, a 0.5mL syringe covers doses up to 1.25mg (50 units)
Zhu B, Gong N, Fan H, Peng CS, Ding XJ, Jiang Y, Wang YX
A good metric to consider is this: If an obese patient (BMI 30 to 34.9) is on a GLP-1 for six months and has not reached 10% TBWL, they should be referred back to their primary care provider to reassess their weight-loss plan